Hipolin (BSE 530853)₹82.50+2.48%Household Products
In the Jun 2026 quarter (consolidated), Hipolin reported sales of ₹5.21 Cr, up 59.8% from Jun 2025, and net profit of ₹0.03 Cr. For the year to Mar 2026, sales were ₹14.16 Cr and net profit −₹0.78 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.09 | 5.35 | 5.86 | 6.60 | 5.51 | 5.05 | 4.39 | 3.26 | 3.17 | 3.77 | 3.95 | 5.21 |
| Expenses | 4.62 | 5.43 | 6.08 | 6.61 | 5.97 | 5.63 | 6.75 | 4.00 | 3.19 | 3.83 | 3.93 | 5.21 |
| Operating Profit | −0.50 | −0.04 | −0.20 | 0.01 | −0.42 | −0.56 | −2.32 | −0.71 | 0.00 | −0.05 | 0.01 | 0.00 |
| OPM % | −12.5% | −0.9% | −3.6% | 0.3% | −7.8% | −11.4% | −53.0% | −22.1% | 0.0% | −1.6% | 0.5% | 0.0% |
| Other Income | 0.21 | 0.11 | 0.11 | 0.10 | 0.12 | 0.07 | 0.13 | 0.06 | 0.06 | 0.12 | 0.06 | 0.06 |
| Interest | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | 0.02 | 0.12 | 0.03 | 0.01 | 0.01 | 0.03 | 0.00 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Profit before tax | −0.36 | 0.02 | −0.17 | 0.06 | −0.39 | −0.57 | −2.37 | −0.74 | 0.02 | 0.02 | 0.02 | 0.03 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | −0.36 | 0.02 | −0.17 | 0.06 | −0.39 | −0.58 | −2.37 | −0.75 | 0.00 | 0.02 | 0.02 | 0.03 |
| EPS (Rs) | −1.11 | 0.02 | −0.50 | 0.15 | −1.20 | −1.81 | −7.51 | −2.35 | 0.00 | 0.02 | 0.02 | 0.05 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|
| Sales | 12.23 | 15.55 | 19.74 | 21.54 | 14.16 | 16.10 |
| Expenses | 13.49 | 16.80 | 20.97 | 24.94 | 14.45 | 16.16 |
| Operating Profit | −1.23 | −1.19 | −1.17 | −3.28 | −0.25 | −0.04 |
| OPM % | −10.2% | −7.7% | −6.0% | −15.3% | −1.9% | −0.3% |
| Other Income | 0.26 | 8.97 | 0.49 | 0.38 | −0.32 | 0.30 |
| Interest | 0.05 | 0.04 | 0.08 | 0.25 | 0.10 | 0.05 |
| Depreciation | 0.05 | 0.07 | 0.08 | 0.08 | 0.08 | 0.04 |
| Profit before tax | −1.12 | 7.65 | −0.89 | −3.28 | −0.78 | 0.09 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Exceptional items | 0.00 | 8.97 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | −1.12 | 7.64 | −0.90 | −3.29 | −0.78 | 0.07 |
| EPS (Rs) | −3.52 | 24.27 | −2.83 | −10.42 | −2.45 | 0.09 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 3.12 | 3.12 | 3.12 | 3.14 | 3.12 |
| Reserves | 1.54 | 9.16 | 8.27 | 5.00 | 4.25 |
| Borrowings | 1.11 | 0.77 | 2.09 | 2.88 | 0.52 |
| Other Liabilities | 4.80 | 1.79 | 2.79 | 1.95 | 3.10 |
| Total Liabilities | 10.57 | 14.84 | 16.27 | 12.97 | 10.99 |
| Fixed Assets | 3.58 | 4.94 | 4.95 | 4.89 | 4.82 |
| CWIP | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.19 | 3.49 | 3.29 | 0.68 | 0.25 |
| Other Assets | 6.56 | 6.41 | 8.03 | 7.40 | 5.92 |
| Inventories | 0.50 | 1.09 | 1.24 | 1.27 | 1.38 |
| Trade receivables | 1.60 | 2.01 | 3.60 | 3.04 | 1.81 |
| Cash & equivalents | 2.81 | 0.35 | 0.15 | 0.28 | 0.10 |
| Total Assets | 10.57 | 14.84 | 16.27 | 12.97 | 10.99 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from operating activity | 3.06 | −5.06 | −1.62 | −3.19 | 1.65 |
| Cash from investing activity | −2.60 | 5.35 | 0.45 | 2.77 | 0.60 |
| Cash from financing activity | −0.53 | −0.38 | 1.24 | 0.53 | −2.39 |
| Net cash flow | −0.05 | −0.08 | 0.05 | 0.11 | −0.16 |
| Capex | 0.27 | 0.38 | 0.09 | 0.02 | 0.02 |
| Free cash flow | 2.90 | 3.76 | −1.70 | −3.20 | 2.03 |
| CFO / OP % | −242.1% | 420.0% | 135.9% | 96.9% | −631.1% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor days | 47 | 47 | 66 | 51 | 46 |
| Inventory days | 24 | 41 | 39 | 38 | 52 |
| Days payable | 25 | 42 | 68 | 42 | 54 |
| Cash conversion cycle | 43 | 42 | 34 | 44 | 42 |
| Working capital days | −107 | 22 | 4 | 6 | −5 |
| ROCE % | — | −9.4% | −5.9% | −24.6% | −1.7% |
For the Jun 2026 quarter, Hipolin reported sales of ₹5.21 Cr, up 59.8% year on year and net profit of ₹0.03 Cr. The operating margin was 0.0%.
Hipolin's sales for the year to Mar 2026 were ₹14.16 Cr; over the last twelve months they were ₹16.10 Cr.
Net profit for the year to Mar 2026 was −₹0.78 Cr, and ₹0.07 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.09.
Hipolin reported borrowings of ₹0.52 Cr at Mar 2026, against cash and equivalents of ₹0.10 Cr.
Cash from operations was ₹1.65 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹2.03 Cr.